Pharmaceutical significance of Eudragit: A review

[1]  B. Mandal Preparation and Physicochemical Characterization of Eudragit ® RL100 Nanosuspension with potential for Ocular Delivery of Sulfacetamide , 2010 .

[2]  T. Baykara,et al.  Studies on Transdermal Delivery Enhancement of Zidovudine , 2009, AAPS PharmSciTech.

[3]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[4]  S. Jacob,et al.  Journal of Basic and Clinical Pharmacy Formulation and Evaluation of Enteric Coated Tablets of Proton Pump Inhibitor , 2022 .

[5]  A. Riga,et al.  Sulfacetamide loaded Eudragit® RL100 nanosuspension with potential for ocular delivery. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[6]  Sougata Jana,et al.  In-vitro release of acyclovir loaded Eudragit RLPO(®) nanoparticles for sustained drug delivery. , 2014, International journal of biological macromolecules.

[7]  R. Pai,et al.  Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal , 2016, Drug delivery.

[8]  S. M. Kakade,et al.  Formulation and evaluation of orally disintegrating tablet containing tramadol hydrochloride by mass extrusion technique , 2011 .

[9]  Kangarlou Sogol,et al.  Mechanical influence of static versus dynamic loadings on parametrical analysis of plasticized ethyl cellulose films. , 2011, International journal of pharmaceutics.

[10]  H. Faghihian,et al.  Preparation and Characterization of Metoprolol Controlled-Release Solid Dispersions , 2006, Drug delivery.

[11]  P. Minghetti,et al.  Dermal patches for the controlled release of miconazole: influence of the drug concentration on the technological characteristics. , 1999, Drug development and industrial pharmacy.

[12]  Formulation and characterization of floating microballoons of Nizatidine for effective treatment of gastric ulcers in murine model , 2015, Drug delivery.

[13]  Wenjing Hu,et al.  Formulation and evaluation of gastroretentive floating drug delivery system of dipyridamole , 2015, Drug development and industrial pharmacy.

[14]  J. Álvarez-Fuentes,et al.  Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium. , 1999, Drug development and industrial pharmacy.

[15]  I. Singh,et al.  Iron oxide induced enhancement of mucoadhesive potential of Eudragit RLPO: formulation, evaluation and optimization of mucoadhesive drug delivery system , 2013, Expert opinion on drug delivery.

[16]  A. Pawar,et al.  Improved bioavailability of orally administered andrographolide from pH-sensitive nanoparticles , 2010, European Journal of Drug Metabolism and Pharmacokinetics.

[17]  Anroop B Nair,et al.  Loratidine buccal films for allergic rhinitis: development and evaluation , 2014, Drug development and industrial pharmacy.

[18]  N. Jain,et al.  Curcumin Loaded Microsponges for Colon Targeting in Inflammatory Bowel Disease: Fabrication, Optimization, and In Vitro and Pharmacodynamic Evaluation , 2014, BioMed research international.

[19]  C. Weng,et al.  Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method. , 2003, The Journal of veterinary medical science.

[20]  Xing Tang,et al.  Development of a Tamsulosin Hydrochloride Controlled-Release Capsule Consisting of Two Different Coated Pellets , 2009, Drug development and industrial pharmacy.

[21]  A. Nokhodchi,et al.  Development of pH-sensitive Insulin Nanoparticles using Eudragit L100-55 and Chitosan with Different Molecular Weights , 2010, AAPS PharmSciTech.

[22]  C. Chaw,et al.  Preparation and characterization of enteric microparticles by coacervation , 2013, Drug development and industrial pharmacy.

[23]  E. Bendas,et al.  Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  T. Shinoda,et al.  Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating. , 2011, International journal of pharmaceutics.

[25]  A. Date,et al.  Eudragit EPO nanoparticles: application in improving therapeutic efficacy and reducing ulcerogenicity of meloxicam on oral administration. , 2011, Journal of biomedical nanotechnology.

[26]  Yanfei Luo,et al.  Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion , 2012, Drug development and industrial pharmacy.

[27]  Stuart L. Cantor,et al.  Formulation and Characterization of a Compacted Multiparticulate System for Modified Release of Water-Soluble Drugs—Part II Theophylline and Cimetidine , 2009, Drug development and industrial pharmacy.

[28]  C. Du,et al.  Enhanced efficacy of curcumin with phosphatidylserine-decorated nanoparticles in the treatment of hepatic fibrosis , 2017, Drug delivery.

[29]  K. Dua,et al.  Formulation and evaluation of transdermal patches of donepezil. , 2015, Recent patents on drug delivery & formulation.

[30]  M. S. Sajeev,et al.  Sustained release enteric coated tablets of pantoprazole: Formulation, in vitro and in vivo evaluation , 2013, Acta pharmaceutica.

[31]  F. Hu,et al.  A novel subcutaneous infusion delivery system based on osmotic pump: in vitro and in vivo evaluation , 2014, Drug delivery.

[32]  V. Singh,et al.  Development and characterization of lysine-methotrexate conjugate for enhanced brain delivery , 2016, Drug delivery.

[33]  K. Mukkanti,et al.  Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization , 2010, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.

[34]  Jin Sun,et al.  Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets. , 2012, International journal of pharmaceutics.

[35]  V. Kadam,et al.  pH-responsive dual pulse multiparticulate dosage form for treatment of rheumatoid arthritis , 2010, Drug development and industrial pharmacy.

[36]  Liuqing Di,et al.  Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement. , 2014, International journal of pharmaceutics.

[37]  V. K. Rai,et al.  Novel drug delivery system: an immense hope for diabetics , 2016, Drug delivery.

[38]  A. Qandil,et al.  Fast and pH-dependent release of domperidone from orally disintegrating tablets , 2013, Pharmaceutical development and technology.

[39]  G. Van den Mooter,et al.  Eudragit E PO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged eudragit L100 copolymers. , 2013, Molecular pharmaceutics.

[40]  Rok Dreu,et al.  Development of a multiple-unit tablet containing enteric-coated pellets , 2011, Pharmaceutical development and technology.

[41]  U. Shinde,et al.  Eudragit RL100 based microspheres for ocular administration of azelastine hydrochloride , 2012, Journal of microencapsulation.

[42]  C. Brahma,et al.  Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers , 2013, International journal of applied & basic medical research.

[43]  S. Saraf,et al.  Preparation and evaluation of sustained release microballoons of propranolol , 2011, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.

[44]  R. Gannu,et al.  Transmucosal delivery of domperidone from bilayered buccal patches: In Vitro, Ex Vivo and In Vivo characterization , 2011, Archives of pharmacal research.

[45]  P. Schmidt,et al.  Development of matrix-based theophylline sustained-release microtablets. , 2000, Drug development and industrial pharmacy.

[46]  Stuart L. Cantor,et al.  Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride , 2015, Drug development and industrial pharmacy.

[47]  W. Pan,et al.  Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions , 2014, International journal of nanomedicine.

[48]  F. Cui,et al.  Development of an osmotically-driven pellet coated with acrylic copolymers (Eudragit® RS 30 D) for the sustained release of oxymatrine, a freely water soluble drug used to treat stress ulcers (I): in vitro and in vivo evaluation in rabbits , 2013, Drug development and industrial pharmacy.

[49]  M. I. Tadros,et al.  Positively Charged Polymeric Nanoparticle Reservoirs of Terbinafine Hydrochloride: Preclinical Implications for Controlled Drug Delivery in the Aqueous Humor of Rabbits , 2013, AAPS PharmSciTech.

[50]  B. Mazumder,et al.  Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology. , 2014, Current drug delivery.

[51]  C. Park,et al.  Electrospun polyurethane/Eudragit ® L100-55 composite mats for the pH dependent release of paclitaxel on duodenal stent cover application. , 2015, International journal of pharmaceutics.

[52]  R. Pignatello,et al.  Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromene , 2006, AAPS PharmSciTech.

[53]  D. Nesseem,et al.  Development of novel transdermal self-adhesive films for tenoxicam, an anti-inflammatory drug. , 2011, Life sciences.

[54]  V. Venkateswarlu,et al.  Design and Evaluation of a Novel Matrix Type Multiple Units as Biphasic Gastroretentive Drug Delivery Systems , 2008, AAPS PharmSciTech.

[55]  Sumeet Gupta,et al.  Buccal films of prednisolone with enhanced bioavailability , 2016, Drug delivery.

[56]  O. Ahmed,et al.  Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis , 2013, Expert opinion on drug delivery.

[57]  C. Cho,et al.  Surface-modified gemcitabine with mucoadhesive polymer for oral delivery† , 2012, Journal of microencapsulation.

[58]  A. Bansal,et al.  Spherical Crystallization of Mebendazole to Improve Processability , 2008 .

[59]  K. Ofokansi,et al.  Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes , 2013, ISRN pharmaceutics.

[60]  Xing Tang,et al.  Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability , 2011, Pharmaceutical development and technology.

[61]  Mohammed Maniruzzaman,et al.  An in‐vitro–in‐vivo taste assessment of bitter drug: comparative electronic tongues study , 2015, The Journal of pharmacy and pharmacology.

[62]  Robert Pfeffer,et al.  Continuous synthesis of polymer-coated drug particles by porous hollow fiber membrane-based antisolvent crystallization. , 2015, Langmuir : the ACS journal of surfaces and colloids.

[63]  G. P. Agrawal,et al.  Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon , 2016, Drug delivery.

[64]  G. Kibria,et al.  Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit , 2009, Indian journal of pharmaceutical sciences.

[65]  Ankita Gupta,et al.  Bilayer Tablet Formulation of Metformin HCl and Acarbose: A Novel Approach To Control Diabetes , 2014, PDA Journal of Pharmaceutical Science and Technology.

[66]  D. Douroumis,et al.  Development and release mechanism of diltiazem HCl prolonged release matrix tablets , 2009, Drug delivery.

[67]  N. Gupta,et al.  Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of vaginal Candidiasis , 2013, Acta pharmaceutica.

[68]  J. Remon,et al.  Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[69]  Cuifang Cai,et al.  Thiolated eudragit-based nanoparticles for oral insulin delivery: preparation, characterization, and evaluation using intestinal epithelial cells in vitro. , 2014, Macromolecular bioscience.

[70]  Monzurul A. Roni,et al.  Effect of Plasticizer on Release Kinetics of Diclofenac Sodium Pellets Coated with Eudragit RS 30 D , 2008, AAPS PharmSciTech.

[71]  M. Abbaspour,et al.  Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination. , 2005, International journal of pharmaceutics.

[72]  S. Pandey,et al.  Formulation and evaluation of bilayered gastroretentable mucoadhesive patch for stomach-specific drug delivery. , 2013, Current drug delivery.

[73]  S. Palma,et al.  Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation. , 2014, Journal of pharmaceutical sciences.

[74]  C. Valenta,et al.  Improvement in physicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  Bin Wang,et al.  Preparation of Eudragit L 100-55 enteric nanoparticles by a novel emulsion diffusion method. , 2013, Colloids and surfaces. B, Biointerfaces.

[76]  Nobuya Kaneko,et al.  Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets , 2012, Drug development and industrial pharmacy.

[77]  A. Talavera,et al.  An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles. , 2013, International journal of pharmaceutics.

[78]  V. Khutoryanskiy,et al.  A laminated polymer film formulation for enteric delivery of live vaccine and probiotic bacteria. , 2014, Journal of pharmaceutical sciences.

[79]  Huixia Lv,et al.  Amorphous solid dispersion with increased gastric solubility in tandem with oral disintegrating tablets: a successful approach to improve the bioavailability of atorvastatin , 2015, Pharmaceutical development and technology.

[80]  P. Chaudhari,et al.  Design and in vitro evaluation of multiparticulate floating drug delivery system of zolpidem tartarate. , 2012, Colloids and surfaces. B, Biointerfaces.

[81]  Mahfoozur Rahman,et al.  Development and optimization of controlled release bioerodable anti infective ophthalmic insert. , 2014, Current drug delivery.

[82]  D. Mishra,et al.  Comparative release profile of sustained release matrix tablets of verapamil HCl , 2013, International journal of pharmaceutical investigation.

[83]  Shengqi Wang,et al.  Design and evaluation of biodegradable enteric microcapsules of amifostine for oral delivery. , 2013, International journal of pharmaceutics.

[84]  D. Baviskar,et al.  Development of Matrix-Type Transdermal Delivery of Lornoxicam: In Vitro Evaluation and Pharmacodynamic and Pharmacokinetic Studies in Albino Rats , 2013, PDA Journal of Pharmaceutical Science and Technology.

[85]  M. Repka,et al.  Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology , 2013, Pharmaceutical development and technology.

[86]  Manik,et al.  Formulation of Sustained-Release Dosage Form of Verapamil Hydrochloride by Solid Dispersion Technique Using Eudragit RLPO or Kollidon®SR , 2009, AAPS PharmSciTech.

[87]  Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer. , 2009, Pakistan journal of pharmaceutical sciences.

[88]  A. Elshafeey,et al.  Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: in-vitro and in-vivo characterization. , 2014, International journal of pharmaceutics.

[89]  F. Alanazi,et al.  Investigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit S 100 , 2014, Acta pharmaceutica.

[90]  L. Kong,et al.  Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon , 2015, Journal of microencapsulation.

[91]  Yan Li,et al.  Preparation and in vitro/in vivo characterization of enteric-coated nanoparticles loaded with the antihypertensive peptide VLPVPR , 2014, International journal of nanomedicine.

[92]  R. Beck,et al.  Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells , 2014, International journal of nanomedicine.